This article highlights the underrepresentation of racial and ethnic populations in atrial fibrillation clinical trials, especially trials focused on stroke prevention. Specific strategies are proposed for future research and initiatives that have potential to eliminate racial and ethnic differences in the care of patients with atrial fibrillation.